Byline Bancorp vs QCR
BY and QCRH side by side, both in commercial banks. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BY and QCRH compare
Byline Bancorp and QCR are about the same size, with market caps of $1.7B and $1.7B.
On earnings, Byline Bancorp is cheaper: it trades at 11.6× trailing earnings, against 12.0× for QCR.
Byline Bancorp grew revenue faster over the last twelve months (10.2% versus −2.3% for QCR).
QCR keeps more of each dollar of sales as profit, with a net margin of 35.8% compared with 32.3% at Byline Bancorp.
Both pay dividends: Byline Bancorp yields 1.2% and QCR 0.40%.
Byline Bancorp scores higher on the StockData Score (14 against 13 for QCR), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BY | QCRH |
|---|---|---|
| Size and price | ||
| Market cap | $1.7B | $1.7B |
| Share price | $38.50 | $101.38 |
| Change, 1 year | 42.9% | 38.6% |
| Change, 5 years | 39.6% | 69.0% |
| Beta (5Y) | 0.70 | 0.70 |
| Employees | 1,027 | 967 |
| StockData Score | ||
| Total score | 14 (better) | 13 |
| Valuation score | 1 | 1 |
| Growth score | 1 | 1 |
| Performance score | 5 | 5 |
| Health score | 3 | 4 (better) |
| Dividend score | 4 (better) | 2 |
| Valuation | ||
| P/E | 11.6× (better) | 12.0× |
| P/S | 3.8× (better) | 4.2× |
| P/B | 1.3× (better) | 1.4× |
| P/FCF | 10.7× | 2.1× (better) |
| PEG | 1.60 | 1.42 (better) |
| FCF yield | 9.3% | 47.8% (better) |
| Fair value | $35.65 | $90.55 |
| Margin of safety | −8.0% (better) | −12.0% |
| Growth | ||
| Revenue growth (TTM) | 10.2% (better) | −2.3% |
| Revenue growth, 5Y average | 10.0% (better) | 3.4% |
| Net income growth (TTM) | 25.6% | 25.9% (better) |
| EPS growth (TTM) | 23.5% | 27.2% (better) |
| EPS growth, 5Y average | 24.7% (better) | 14.5% |
| Profitability | ||
| Net margin | 32.3% | 35.8% (better) |
| FCF margin | 35.1% | 200% (better) |
| Return on equity | 12.0% | 12.9% (better) |
| Financial health | ||
| Debt / equity | – | 0.01 |
| Altman Z-score | 0.27 | 0.28 (better) |
| Piotroski F-score | 6 | 6 |
| Dividends and buybacks | ||
| Dividend yield | 1.2% (better) | 0.40% |
| Payout ratio | 13.4% | – |
| Years of dividend growth | 1 (better) | 0 |
| Dividend growth, 5Y average | 27.2% (better) | 0.00% |
| Buyback yield | 1.6% (better) | −0.16% |
| Shareholder yield | 2.8% (better) | 0.25% |
| Ownership | ||
| Held by institutions | 55.2% | 77.6% |
| Held by insiders | 28.7% | 3.1% |
| Insider net buying, 12 months | −$24.4M | −$903K (better) |
| Short interest, % of float | 4.4% | 3.5% |
Go deeper
- BY stock overview
- BY income statement
- BY valuation and score
- QCRH stock overview
- QCRH income statement
- QCRH valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.